World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
12892
World Ranking
3950
National Ranking
1808

Overview

James G. Kublin is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on medicine and immunology and microbiology, with significant contributions to the fields of infectious diseases, virology, immunology, health, and epidemiology.

The scientist's work extensively covers topics related to SARS-CoV-2 and COVID-19 research, HIV research and treatment, COVID-19 clinical research studies, vaccine coverage and hesitancy, HIV/AIDS research and interventions, vaccines and immunoinformatics approaches, as well as malaria research and control.

Key recent publications include:

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial, 2022, Science
  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition, 2021, New England Journal of Medicine
  • Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults, 2021, New England Journal of Medicine
  • Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment, 2021, PLoS ONE

Frequent co-authors in their body of work include Lawrence Corey, Peter B. Gilbert, Glenda Gray, Yunda Huang, and Lindsey R. Baden.

The most common publication venues where their research appears are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • The Journal of Infectious Diseases
  • Nature Communications
  • Clinical Infectious Diseases

The scientific contributions of James G. Kublin are concentrated in studies that intersect clinical research and vaccine development, particularly involving HIV and COVID-19. The research covers vaccine efficacy trials, immune response correlates, and strategies to increase diversity in clinical trial participation.

Best Publications

  • Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.

    Peter B Gilbert;Peter B Gilbert;David C Montefiori;Adrian B McDermott;Youyi Fong

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Molecular Markers for Failure of Sulfadoxine-Pyrimethamine and Chlorproguanil-Dapsone Treatment of Plasmodium falciparum Malaria

    James G. Kublin;Fraction K. Dzinjalamala;Deborah D. Kamwendo;Elissa M. Malkin

  • Reemergence of Chloroquine-Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi

    James G Kublin;Joseph F Cortese;Eric Mbindo Njunju;Rabia A G. Mukadam

  • Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa.

    Laith J. Abu-Raddad;Laith J. Abu-Raddad;Padmaja Patnaik;James G. Kublin;James G. Kublin

  • Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?

    Carol Hopkins Sibley;John E Hyde;Paul F.G Sims;Christopher V Plowe

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

    Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard

  • Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study

    James G Kublin;Padmaja Patnaik;Charles S Jere;William C Miller

  • Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

    Frances H. Priddy;Deborah Brown;James Kublin;Kathleen Monahan

  • Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

    Spyros A. Kalams;Scott D. Parker;Marnie Elizaga;Barbara Metch

  • Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

    Glenda E. Gray;Glenda E. Gray;Glenda E. Gray;Linda Gail Bekker;Fatima Laher;Mookho Malahleha

  • Effects of HIV-1 Serostatus, HIV-1 RNA Concentration, and CD4 Cell Count on the Incidence of Malaria Infection in a Cohort of Adults in Rural Malawi

    Padmaja Patnaik;Charles S. Jere;William C. Miller;Irving F. Hoffman

  • Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

    Nicole Frahm;Allan C. DeCamp;David P. Friedrich;Donald K. Carter

  • Tuberculosis Vaccines and Prevention of Infection

    Thomas R. Hawn;Tracey A. Day;Thomas J. Scriba;Mark Hatherill

  • Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization

    Cecilia Rademeyer;Bette Korber;Michael S Seaman;Elena E Giorgi

  • Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

    Glenda E. Gray;Glenda E. Gray;Zoe Moodie;Barbara Metch;Peter B. Gilbert

  • Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.

    A Alloueche;W Bailey;S Barton;J Bwika

  • Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

    Unknown

  • Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study

    Christopher V Plowe;James G Kublin;Fraction K Dzinjalamala;Deborah S Kamwendo

  • Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

    Peter B. Gilbert;David C. Montefiori;David C. Montefiori;Adrian McDermott;Youyi Fong

Frequent Co-Authors

Glenda Gray
Glenda Gray South African Medical Research Council
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
M. Juliana McElrath
M. Juliana McElrath University of Washington
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
David C. Montefiori
David C. Montefiori Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute
Nicole Frahm
Nicole Frahm Fred Hutchinson Cancer Research Center
Koleka Mlisana
Koleka Mlisana National Health Laboratory Service

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open up diverse career opportunities in healthcare and research. Nursing programs, particularly those with more accessible admission criteria, provide a practical pathway for gaining clinical experience. Prospective students might consider lpn programs with easiest admission requirements, which offer a solid foundation for patient care roles.

Nurse Practitioner (NP) programs are another excellent route, especially for those aiming to specialize in advanced clinical roles. Programs recognized as easiest np programs to get into can be ideal for learners seeking flexible and accessible options without compromising quality.

Mental health is a growing field closely linked to immunological research and health outcomes. Online PMHNP (Psychiatric Mental Health Nurse Practitioner) programs with high success in clinical training placements can greatly enhance practical experience. Exploring pmhnp programs online with best clinical placement helps ensure hands-on learning that is crucial for this specialty.

Budget considerations are also important when selecting a program. Investigating cheapest psych np programs online offers affordable pathways to enter psychiatric nursing, which complements immunology careers focused on neuroimmune interactions.

Best Scientists Citing James G. Kublin

Trending Scientists

Recently Published Articles